Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Movantik
Movantik
Nektar sells off royalties on its 2 approved drugs for $150M in cash, redoubling focus on I-O candidates
Nektar sells off royalties on its 2 approved drugs for $150M in cash, redoubling focus on I-O candidates
Endpoints
Nektar Therapeutics
Adynovate
Movantik
HealthCare Royalty Partners
Flag link:
AstraZeneca, still in asset-sale mode, hands off most global rights for constipation med Movantik
AstraZeneca, still in asset-sale mode, hands off most global rights for constipation med Movantik
Fierce Pharma
AstraZeneca
Redhill Biopharma
constipation
Movantik
Flag link:
Nektar (NKTR) Stock Up More than 300% This Year: Here's Why
Nektar (NKTR) Stock Up More than 300% This Year: Here's Why
Yahoo/Zacks.com
Nektar
AstraZeneca
Movantik
Onzeald
UCB Pharma
Cimzia
Amgen
Neulasta
Flag link:
Daiichi shells out $200M-plus to help AstraZeneca launch Movantik
Daiichi shells out $200M-plus to help AstraZeneca launch Movantik
Fierce Pharma
Daiichi Sankyo
AstraZeneca
Movantik
constipation
Flag link:
How Will AstraZeneca (AZN) Stock React to FDA's Movantik Approval?
How Will AstraZeneca (AZN) Stock React to FDA's Movantik Approval?
TheStreet.com
AstraZeneca
Movantik
FDA
opioid-induced constipation
Nektar
Flag link:
FDA approves AstraZeneca, Nektar constipation drug
FDA approves AstraZeneca, Nektar constipation drug
Yahoo/Reuters
FDA
AstraZeneca
Nektar
Movantik
opioid-induced constipation
Flag link:
